These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 132786)

  • 1. [Adriamycin, cyclophosphamide, and 5-fluorouracil in the treatment of metastasizing breast cancer (author's transl)].
    Höffken K; Seeber S; Boecker WR; Schmidt CG
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Jun; 86(2):135-45. PubMed ID: 132786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)].
    Michlmayr G; Kratzer H; Denz H; Huber H
    Wien Klin Wochenschr; 1981 Mar; 93(6):205-7. PubMed ID: 7281697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoimmunotherapy of advanced breast cancer: prolongation of remission and survival with BCG.
    Gutterman JU; Cardenas JO; Blumenschein GR; Hortobagyi G; Burgess MA; Livingston RB; Mavligit GM; Freireich EJ; Gottlieb JA; Hersh EM
    Br Med J; 1976 Nov; 2(6046):1222-5. PubMed ID: 791447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of metastatic breast cancer with adriamycin-cyclophosphamide induction followed by alternating combination therapy.
    Abeloff MD; Ettinger DS
    Cancer Treat Rep; 1977 Dec; 61(9):1685-9. PubMed ID: 340033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effect of combination of cyclophosphamide, adriamycin and platinum (CAP) versus cyclophosphamide, adriamycin and 5-fluorouracil (CAF) in metastatic breast cancer.
    Tzekova V; Velikova M; Koynov K; Micheva D; Donchev T
    Neoplasma; 1991; 38(6):603-7. PubMed ID: 1766485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adriamycin-combination chemotherapy with or without immune stimulation by corynebacterium parvum in metastasizing carcinoma of the breast (author's transl)].
    Mayr AC; Senn HJ; Gallmeier WM; Bruntsch U; Becher R; Drings P; Fritze D; Kaufmann M; Queisser W; Kempgens U
    Dtsch Med Wochenschr; 1979 Dec; 104(49):1739-43. PubMed ID: 510206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer.
    De Lena M; Brambilla C; Morabito A; Bonadonna G
    Cancer; 1975 Apr; 35(4):1108-15. PubMed ID: 1116104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adriamycin plus alkylating agents in the treatment of metastatic breast cancer.
    Lokich JJ; Skarin AT; Mayer RJ; Henderson IC; Blum RH; Frei E
    Cancer; 1977 Dec; 40(6):2801-5. PubMed ID: 338136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of cyclophosphamide, adriamycin and platinum (CAP) versus 5-fluorouracil, adriamycin and cyclophosphamide (FAC) as primary treatment in metastatic breast cancer: results of a prospective randomized study.
    Kolarić K; Vukas D; Potrebica V
    Tumori; 1989 Apr; 75(2):132-6. PubMed ID: 2741218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy.
    Bull JM; Tormey DC; Li SH; Carbone PP; Falkson G; Blom J; Perlin E; Simon R
    Cancer; 1978 May; 41(5):1649-57. PubMed ID: 348293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAP (cyclophosphamide, adriamycin, platinum) vs CMFVP (cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisolone) combination chemotherapy in untreated metastatic breast cancer. A preliminary report of a controlled clinical study.
    Kolarić K; Roth A; Vukas D; Cervek J
    Cancer Chemother Pharmacol; 1984; 13(2):142-4. PubMed ID: 6380789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG.
    Hortobagyi GN; Gutterman JU; Blumenschein GR; Tashima CK; Burgess MA; Einhorn L; Buzdar AU; Richman SP; Hersh EM
    Cancer; 1979 Nov; 44(5):1955-62. PubMed ID: 387212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project.
    Smalley RV; Carpenter J; Bartolucci A; Vogel C; Krauss S
    Cancer; 1977 Aug; 40(2):625-32. PubMed ID: 329975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy for metastatic breast cancer: comparison of multiple drug therapy with 5-fluorouracil, cytoxan and prednisone with adriamycin or adrenalectomy.
    Nemoto T; Rosner D; Diaz R; Dao T; Sponzo R; Cunningham T; Horton J; Simon R
    Cancer; 1978 Jun; 41(6):2073-7. PubMed ID: 657080
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination chemotherapy for advanced breast cancer: two regimens containing adriamycin.
    Kennealey GT; Boston B; Mitchell MS; Knobf MK; Bobrow SN; Pezzimenti JF; Lawrence R; Bertino JR
    Cancer; 1978 Jul; 42(1):27-33. PubMed ID: 667798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin.
    Creech RH; Catalano RB; Harris DT; Engstrom PF; Grotzinger PJ
    Cancer; 1979 Jan; 43(1):51-9. PubMed ID: 367574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG.
    Hortobagyi GN; Gutterman JU; Blumenschein GR; Tashima CK; Burgess MA; Einhorn L; Buzdar AU; Richman SP; Hersh EM
    Cancer; 1979 Apr; 43(4):1225-33. PubMed ID: 445325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy of metastasizing breast cancers. Indications and results].
    Gallmeier WM; Bruntsch U; Schmidt CG
    Dtsch Med Wochenschr; 1975 Jan; 100(2):35-41. PubMed ID: 1112210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ifosfamide versus cyclophosphamide in combination drug therapy for metastatic breast cancer.
    Buzdar AU; Legha SS; Tashima CK; Yap HY; Hortobagyi GN; Hersh EM; Blumenschein GR; Bodey GP
    Cancer Treat Rep; 1979 Jan; 63(1):115-20. PubMed ID: 369682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of adriamycin in metastatic breast cancer resistant to a combination regimen with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prdnisone.
    Frederiksen PL; Joergensen ST; Roesdahl K; Thomsen J; Mouridsen HT
    Cancer Treat Rep; 1978 Mar; 62(3):449-50. PubMed ID: 348314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.